The use of neoadjuvant systemic therapy in the treatment of breast cancer patients is
increasing beyond the scope of locally advanced disease. Imaging provides important …

Diffusion‐weighted imaging (DWI) is increasingly being incorporated into routine breast MRI
protocols in many institutions worldwide, and there are abundant breast DWI indications …

Objective To develop different radiomic models based on the magnetic resonance imaging
(MRI) radiomic features and machine learning methods to predict early intensity-modulated …

Objectives The purpose of this study was to determine whether multiparametric magnetic
resonance imaging (MRI) using dynamic contrast-enhanced MRI (DCE-MRI) and diffusion …

Pathologic complete remission after neoadjuvant chemotherapy has a role in guiding the
management of breast cancer. The present meta-analysis examined the accuracy of contrast …

Although there are considerable data on the use of mathematical modeling to describe
tumor growth and response to therapy, previous approaches are often not of the form that …

Clinical evidence regarding the value of MRI for therapy responses assessment in breast
cancer is increasing. The objective of this study is to compare the diagnostic capability of …

Imaging biomarkers for the predictive assessment of treatment response in patients with
cancer earlier than standard tumor volumetric metrics would provide new opportunities to …

The purpose of this study was to evaluate the capacity of diffusion-weighted magnetic
resonance imaging (DW-MRI) for early prediction of pathological response in breast cancer …

Patients with locally advanced invasive breast cancers are often treated with neoadjuvant
chemotherapy prior to definitive surgical intervention. The primary aims of this approach are …